IRCT201307182181N6已完成未知
Adjunctive treatment with Aripiprazole for Risperidone –induced hyperprolactinemia
tabriz university of medical science0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 49 years（—）
- 性别
- Female
入选标准
- •inclusion criterias :
- •1.hyperprolactinemia
- •2. women in reproductive age
- •3.candidate for risperidone continuation
- •exclusion criterias:
- •1.previous amenorrhea
- •2.breastfeeding
- •3.pregnancy
- •4.renal failure
- •5. hypothyroidism
- •6. pituitary tumors
- •7. consumption of methyldopa, levodopa,cimethidine, strogen, opium derivatives
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Augmentation therapy with aripiprazole in selective serotonin reuptake inhibitor(SSRI)-refractory obsessive-compulsive disorder(OCD); A randomized double blind placebo controlled trialobsessive-compulsive disorderJPRN-UMIN000008743Kyushu University60
招募中
不适用
Aripiprazole augmentation for somatic symptoms of depressioKCT0004607Chung-Ang Univerisity Hospital52
已完成
不适用
A clinical trial to study the effects of Aripiprazole in Risperidone induced increased prolactin level and its consequences.CTRI/2012/11/003114ICMR30
进行中（未招募）
不适用
A pilot study of Aripiprazole treatment for antipsychotic induced hyperprolactinaemia in young patients with severe mental illness and learning disabilities. - Aripiprazole and Prolactin Study- Version 1Antipsychotic induced hyperprolactinaemiaMedDRA version: 12Level: LLTClassification code 10020737Term: HyperprolactinaemiaEUCTR2009-011228-73-GBniversity of Oxford
尚未招募
1 期
Comparison of Efficacy of Aripiprazole versus Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment of Resistant Obsessive Compulsive Disorder: A Randomized Controlled TrialObsessive Compulsive Disorder.Obsessive-compulsive disorderIRCT20230526058298N1Postgraduate Medical Institute Lahore44